1. Home
  2. STTK vs SHIM Comparison

STTK vs SHIM Comparison

Compare STTK & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.95

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.96

Market Cap

123.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
SHIM
Founded
2016
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
123.6M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
STTK
SHIM
Price
$3.95
$3.96
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$6.20
N/A
AVG Volume (30 Days)
319.7K
58.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.32
N/A
EPS
N/A
N/A
Revenue
$5,721,000.00
$480,236,000.00
Revenue This Year
N/A
$6.91
Revenue Next Year
N/A
$13.03
P/E Ratio
N/A
N/A
Revenue Growth
245.26
N/A
52 Week Low
$0.69
$1.30
52 Week High
$4.89
$4.47

Technical Indicators

Market Signals
Indicator
STTK
SHIM
Relative Strength Index (RSI) 46.85 55.78
Support Level $3.52 $3.35
Resistance Level $4.23 $4.10
Average True Range (ATR) 0.28 0.27
MACD -0.02 -0.03
Stochastic Oscillator 23.85 56.60

Price Performance

Historical Comparison
STTK
SHIM

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: